Although in a large retrospective cohort study a greater mortality from malignant disease and colon cancer in patients with elevated GH has been reported [104], overall cancer risk was slightly, but not significantly, increased in a recent 20-year cohort matched study [105]. The gene discussed is GH1; the disease is cancer.